Field Trip Health Ltd. (FTRP): Price and Financial Metrics


Field Trip Health Ltd. (FTRP): $0.85

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

FTRP Stock Price Chart Interactive Chart >

Price chart for FTRP

FTRP Price/Volume Stats

Current price $0.85 52-week high $6.41
Prev. close $0.85 52-week low $0.71
Day low $0.84 Volume 42,342
Day high $0.85 Avg. volume 215,276
50-day MA $0.83 Dividend yield N/A
200-day MA $1.86 Market Cap 49.43M

Field Trip Health Ltd. (FTRP) Company Bio


Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; and Field Trip Discovery, a drug development division developing the next generation of psychedelic molecules. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.


FTRP Latest News Stream


Event/Time News Detail
Loading, please wait...

FTRP Latest Social Stream


Loading social stream, please wait...

View Full FTRP Social Stream

Latest FTRP News From Around the Web

Below are the latest news stories about Field Trip Health Ltd that investors may wish to consider to help them evaluate FTRP as an investment opportunity.

Bloom Burton Thinks Field Trip Health’s Stock is Going to Recover

In a report released today, David Martin PhD from Bloom Burton maintained a Buy rating on Field Trip Health (FTRP – Research Report), with a price target of $9.50. The company's shares closed last Thursday at $1.59, close to its 52-week low of $1.51. According to TipRanks.com, PhD is ranked #659 out of 7805 analysts. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Field Trip Health with a $12.14 average price target, implying a 663.5% upside from current levels. In a report issued on February 2, Maxim Group also maintained a Buy rating on the stock with a $5.00 price target.

Brian Anderson on TipRanks | February 17, 2022

Psychedelic Stock Gainers And Losers From February 17, 2022

GAINERS: Mindset Pharma (OTC: MSSTF ) shares closed up 9.89% at $0.55 Small Pharma (OTC: DMTTF ) shares closed up 5.33% at $0.23 Intelgenx Technologies (OTC: IGXT ) shares closed up 1.06% at $0.32 LOSERS: ATAI Life Sciences (NASDAQ: ATAI ) shares closed down 8.49% at $5.71 Field Trip Health (NASDAQ: Full story available on Benzinga.com

Benzinga | February 17, 2022

Field Trip Health Posts 330% YoY Increase In Q3 Revenue

Psychedelics-based company Field Trip Health Ltd. (TSX: FTRP) (NASDAQ: FTRP ) reported its third fiscal quarter 2022 results for the three months ended December 31, 2021 and provided a business update. Q3 Financial Highlights Patient services revenues totaled CA$1.4 million ($1.1 million) from its Toronto, New York, Santa Monica, Chicago, Atlanta, Houston, Fredericton, Seattle, San Diego and Amsterdam clinics, representing an increase of CA$1.04 million or 330% over the comparative quarter ended December 31, 2020 of $316,329 and an increase of $452,995 or 50% over the prior quarter. Net loss amounted to roughly CA$15 million, driven primarily by total operating costs, compared to CA$8.3 million in the corresponding quarter of fiscal … Full story available on Benzinga.com

Benzinga | February 16, 2022

Field Trip Health Ltd. (FTRP) CEO Joseph Del Moral on Q3 2022 - Earnings Call Transcript

No summary available.

Seeking Alpha | February 16, 2022

Field Trip Health  GAAP EPS of -$0.26 misses by $0.08, revenue of $1.36M beats by $0.15M

Field Trip Health  press release (NASDAQ:FTRP): FQ3 GAAP EPS of -$0.26 misses by $0.08. Revenue of $1.36M (+325.0% Y/Y) beats by $0.15M. Shares +1.16% AH....

Seeking Alpha | February 15, 2022

Read More 'FTRP' Stories Here

FTRP Price Returns

1-mo 2.47%
3-mo -9.86%
6-mo -50.87%
1-year -84.43%
3-year N/A
5-year N/A
YTD -65.45%
2021 -24.26%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.481 seconds.